NeuroRx is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for mood disorders when they are associated with Acute Suicidal Ideation & Behavior (ASIB), such as Bipolar Depression, PTSD.
Our first treatment regimen is NRX-100/NRX-101, it is being developed for Bipolar Depression in patients with Acute Suicidal Ideation & Behavior
The NeuroRx team reaches beyond boundaries, thinks beyond standards and explores beyond borders. We have the courage to try what others have not yet tried.
We are a dynamic start-up, committed to our mission of bringing life saving treatments to patients. Most of our colleagues operate out of our Radnor-based clinical office, near Philadelphia.
No open positions at this time.
However, in the development of pharmaceutical products there are frequent changes. Hence, if you believe you can contribute to our development of NRX-100/NRX-101, we would like to hear from you at email@example.com.